Top Back to top

Activity report 2022 of the Global Committee

The EBMT Global committee (EGC) was created by the EBMT Board in October 2017 to further extend the scope of stem cell transplantation and cell therapy to as many transplant teams as possible outside Europe to extend further our common knowledge, medical training and research.


EBMT has made a considerable effort to help our Chinese colleagues to join and not surprisingly this report will deal very much with our common progress in China. 

But the role of the EGC is of course global and we heartily welcome all new members and encourage all members of the EGC to help as much as they can to further increase our scientific knowledge and get benefit for both transplant teams and patients.

The present report is very much oriented to China and the year 2022 has been complicated by COVID. Nonetheless meetings online have never stopped. We hope the next EGC meeting will cover new collaborations with many other countries.

Educational Scientific Meetings

In 2022, three meetings were co-organized by EBMT and Chinese national organisations: two for physicians and one for nurses. Once again the help of the Boxiao foundation including Eva Yu must be acknowledged.

A first EBMT-China inaugural Scientific Forum co-organised by EBMT and the national research centre for translational medicine in Ruijin Hospital, took place  in Shanghai on June 24, 2022, under the co-presidency of our colleagues: Saijuan Chen, Xiaojun Huang, Depei Wu, and He Huang. Weili Zhao and Aibin Liang acted as Executive Presidents. The director of the national centre and a representative of the science and technology commission of the Shanghai municipality assisted us. 300 colleagues were connected online.

A second EBMT-China Scientific Forum co-organized by EBMT, the Institute of haematology and Blood diseases of Tianjin, the Chinese academy of medical sciences and the Pekin Union College, took place in Tianjin on November 18, 2022, under the co-presidency of Jianxiang Wang, Director of the institute and Erlie Jiang, acting as Executive President. The program was devoted to the treatment of Acute Myeloid Leukemia. 500 participants registered and nearly 20,000 watched the forum online since the Tianjin team made a replay of the forum available. Read the event report HERE.

Nicolaus Kroeger, Anna Sureda and Norbert Claude Gorin chaired these forum. 

On the occasion of the 17th National Haematology Academic Conference of the Chinese Medical Association, the first EBMT- China Nursing Forum (in-person and online) was successfully held on September 24, 2022 at the National Exhibition and Convention Center (Shanghai) with the support from Yan Xia, Chairwomen of the Chinese Haematological Disease Nursing Branch and Michelle Kenyon, the EBMT Nurses Group President. Read the event report HERE.

Scientific Production

At the time of writing this report, 6 projects have been initiated by EBMT-China. They are listed below:

  1. A Chinese national survey of transplant activity in China (around 12,000 transplants per year): Dr CHEN Jia as Principal Investigator ( PI): completed
  2. A  retrospective study of the outcomes post haploidentical transplants  comparing first degree versus non first degree donors (oral presentation EBMT 2023): Dr YE Yishan PI: completed
  3. A retrospective comparison of autologous versus haploidentical transplants in adult patients with AML in first remission (CR1) with undetectable Minimal Residual Disease (uMRD): Dr CHEN Jia PI (Poster at EBMT 2023): completed
  4. A retrospective comparison of autologous versus haplo-identical transplants in adult patients with ALL Philadelphia positive receiving TKI as maintenance therapy: Dr RU Yuhua: in progress
  5. A retrospective comparative study of haplo-, MSD and MUD allo-HCTs for AML patients with KMT2A rearrangement: Dr YE Yishan PI (oral presentation at EBMT 2023): patient recruitment still in progress to increase statistical power.
  6. Outcome post HSCTof adult patients with AML carrying a TET2 mutation: Dr LI Lin PI: in progress.

The EGC would like to acknowledge the help for these studies of the Acute Leukaemia Working Party and in particular Myriam Labopin, Jacques Emmanuel Galimard, Irma Khevelidze, Mohamed Houhou and Emmanuelle Polge.

The EGC encourages all Chinese teams to propose study projects in association with any of the existing Working Parties. Projects are discussed at the working party meetings and if approved chaired by the proposing investigator considered as the PI.

Special scientific session

During the 48th EBMT Annual Meeting, the ECG organised a session entitled: “GLOBAL PERSPECTIVE FOR CELLULAR IMMUNE THERAPY” with 5 speakers including 4 from Asia.

New Members

CIC Centre Name City Principal Investigator
401 First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Huang HE
443 Peking University People´s Hospital, Institute of Haematology Beijing Xiao-jun HUANG
931 First Affiliated Hospital of Soochow University Suzhou Depei WU
939 Beijing Jishuitan Hospital Beijing Li BAO
1008 Institute of Hematology, Chinese Academy of Medical Sciences Tianjin Erlie JIANG
1012 Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai Jiong HU
1013 Central South University, Xiangya Hospital Changsha Yajing XU
1014 Union Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan Yu HU
1015 Shenzhen Children's Hospital Shenzhen Sixi LIU
1016 The First Affiliated Hospital of Xi'an Jiaotong University Xi'an Pengcheng HE
1017 Xinqiao Hospital of Army Medical University Chongqing Xi ZHANG
1018 Tongji Hospital Affiliated to Tongji Univerisity Shanghai Aibin LIANG
1023 First Affiliated Hospital of Sun Yat-sen University Guangzhou Juan LI
1024 Lanzhou University Second Hospital Lanzhou Liansheng ZHANG
1025 First Affiliated Hospital of Xinjiang Medical University Urumqi Ming JIANG
1026 Second Affiliated Hospital of Xi'an Jiaotong University Xi'an Aili HE
1027 First Affiliated Hospital of Zhengzhou University Zhengzhou Yufeng LIU
1028 920th Hospital of Joint Logistics Support Force Kunming Sanbin WANG
1029 Beijing Friendship Hospital, Capital Medical University Beijing Zhao WANG
1030 The First Affiliated Hospital of Wenzhou Medical Unviersity Wenzhou Kang YU
1031 Nanfang Hospital, Southern Medical University Guangzhou Qifa LIU
1032 First Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou Baodong YE

Membership overview in the last three years

Membership overview


Global Committee Team

EBMT China Office in Shanghai

In 2021, the EGC was renewed for two years. Most members of the first EGC have expressed their wish to remain on board. You can view the list of members below.

If you wish to join our team, please contact us. Note that two sponsors are needed. In case of difficulties to find a sponsor, the EGC suggests for applicants to join any EGC member (especially if there is one in their own country) and/or to request their application to be forwarded for special evaluation to the EGC chair.

We have been informed that, early 2023, the localization of the EBMT-China Office in Shanghai will move to a new place at a different address, with the same general facilities. The EGC is grateful in particular to Mrs Eva Yu for ensuring constant  connection, help and support linking EBMT Barcelona and Paris Offices to the EBMT China Office and all present Chinese EBMT new team members.

Latin America

Stem cell transplantation and cell therapy are taking off in Latin America. EGC has designated Latin America as its next recruitment effort to come, with the help of EGC Latin America members.